PT  - JOURNAL ARTICLE
AU  - Kuzma, Amanda
AU  - Valladares, Otto
AU  - Greenfest-Allen, Emily
AU  - Nicaretta, Heather
AU  - Kirsch, Maureen
AU  - Ren, Youli
AU  - Katanic, Zivadin
AU  - White, Heather
AU  - Wilk, Andrew
AU  - Bass, Lauren
AU  - Brettschneider, Jascha
AU  - Carter, Luke
AU  - Cifello, Jeffrey
AU  - Chuang, Wei-Hsuan
AU  - Clark, Kaylyn
AU  - Gangadharan, Prabhakaran
AU  - Haut, Jacob
AU  - Ho, Pei-Chuan
AU  - Horng, Wenhwai
AU  - Iqbal, Taha
AU  - Jin, Yumi
AU  - Keskinen, Peter
AU  - Rose, Alexis Lerro
AU  - Moon, Michelle K
AU  - Manuel, Joseph
AU  - Qu, Liming
AU  - Robbins, Flawless
AU  - Saravanan, Naveensri
AU  - Sha, Jin
AU  - Tate, Sam
AU  - Zhao, Yi
AU - Alzheimer’s Disease Sequencing Project
AU  - Cantwell, Laura
AU  - Gardner, Jake
AU  - Chou, Shin-Yi
AU  - Tzeng, Jung-Ying
AU  - Bush, William
AU  - Naj, Adam
AU  - Kuksa, Pavel
AU  - Lee, Wan-Ping
AU  - Leung, Yuk Yee
AU  - Schellenberg, Gerard
AU  - Wang, Li-San
TI  - NIAGADS: A Comprehensive National Data Repository for Alzheimer’s Disease and Related Dementia Genetics and Genomics Research
AID  - 10.1101/2024.10.07.24315029
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.10.07.24315029
4099  - http://medrxiv.org/content/early/2024/12/07/2024.10.07.24315029.short
4100  - http://medrxiv.org/content/early/2024/12/07/2024.10.07.24315029.full
AB  - NIAGADS is the National Institute on Aging (NIA) designated national data repository for human genetics research on Alzheimer’s Disease and related dementia (ADRD). NIAGADS maintains a high-quality data collection for ADRD genetic/genomic research and supports genetics data production and analysis. NIAGADS hosts whole genome and exome sequence data from the Alzheimer’s Disease Sequencing Project (ADSP) and other genotype/phenotype data, encompassing 209,000 samples. NIAGADS shares these data with hundreds of research groups around the world via the Data Sharing Service, a FISMA moderate compliant cloud- based platform that fully supports the NIH Genome Data Sharing Policy. NIAGADS Open Access consists of multiple knowledge bases with genome-wide association summary statistics and rich annotations on the biological significance of genetic variants and genes across the human genome. NIAGADS stands as a keystone in promoting collaborations to advance the understanding and treatment of Alzheimer’s disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNIAGADS is supported by an NIH/NIA collaborative agreement (U24-AG041689).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes